Fast timeline Avitide emphasizes a 3-month concept-to-resin delivery service, which can be leveraged to position a sales conversation around accelerating bioprocess development timelines for potential clients, especially those facing time-to-market pressures.

Integrated downstream The company supports next-generation integrated continuous downstream processing, presenting an opportunity to engage biopharma manufacturers exploring end-to-end, continuous purification solutions and resin supply continuity.

Broad molecule scope Avitide’s affinity technologies have been applied to enzymes, bispecifics, viral vectors, cell therapies, vaccines, and more, suggesting cross-segment selling potential across multiple modalities and stages of development, from discovery to manufacturing.

Quality & supply Operating under ISO 9001:2015 with demonstrated continuity of supply, Avitide can be positioned to address suppliers’ stringent quality and risk-management requirements, appealing to CDMOs and large biopharma needing reliable resin partners.

Strategic fit with Repligen As a Repligen Company, Avitide benefits from a broader bioprocess portfolio and potential for bundled solutions, enabling cross-sell opportunities with existing Repligen customers seeking affinity purification, ligands, and related bioprocessing technologies.